Skip to content
Business Segments · Other segment items

Neuroscience — Other segment items

Medtronic Neuroscience — Other segment items increased by 33.3% to $12M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $12M to $12M. Over 2 years (FY 2023 to FY 2025), Neuroscience — Other segment items shows a downward trend with a -35.3% CAGR.

Analysis

StatementSegment
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2023
Last reportedQ4 2025Feb 24, 2026

How to read this metric

Large fluctuations may signal one-time charges, restructuring costs, or non-recurring gains that require further investigation.

Detailed definition

This category aggregates miscellaneous expenses or income items specific to the Neuroscience segment that do not fit int...

Peer comparison

Similar to 'other operating items' or 'unallocated segment expenses' found in segment reporting for large conglomerates.

Metric ID: mdt_segment_neuroscience_other_segment_items

Historical Data

12 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$18.5M$18.5M$18.5M$18.5M$11M$11M-$4M$12M$8M$2M$9M$12M
QoQ Change+0.0%+0.0%+0.0%-40.5%+0.0%-136.4%+400.0%-33.3%-75.0%+350.0%+33.3%
YoY Change-40.5%-40.5%-121.6%-35.1%-27.3%-81.8%+325.0%+0.0%
Range-$4M$18.5M
CAGR-14.6%
Avg YoY Growth-2.7%
Median YoY Growth-37.8%
Current Streak2 quarters growth

Frequently Asked Questions

What is Medtronic's neuroscience — other segment items?
Medtronic (MDT) reported neuroscience — other segment items of $12M in Q4 2025.
How has Medtronic's neuroscience — other segment items changed year-over-year?
Medtronic's neuroscience — other segment items decreased by 0.0% year-over-year, from $12M to $12M.
What is the long-term trend for Medtronic's neuroscience — other segment items?
Over 2 years (2023 to 2025), Medtronic's neuroscience — other segment items has grown at a -35.3% compound annual growth rate (CAGR), from $74M to $31M.
What does neuroscience — other segment items mean?
Miscellaneous costs or gains specific to the neuroscience business unit.